Sale!

TRMU Gene Liver Failure Transient Infantile Genetic Test

Name: TRMU Gene Liver Failure Transient Infantile Genetic Test
SKU: TEST-3700
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TRMU Gene Liver Failure Transient Infantile Genetic Test is a specialized diagnostic procedure designed to identify mutations in the TRMU gene, which have been associated with transient infantile liver failure. This condition is a rare but critical disorder that typically manifests in the early months of life, characterized by acute liver dysfunction that can spontaneously resolve or lead to severe complications if not promptly diagnosed and managed. The TRMU gene plays a crucial role in mitochondrial function, particularly in the biosynthesis of transfer RNAs, which are essential for protein synthesis within the cell. Mutations in this gene can disrupt mitochondrial function, leading to liver failure among other potential issues.

Conducted at DNA Labs UAE, a leading facility in genetic testing and diagnostics, the test offers families and healthcare professionals vital information for the management of affected infants. The procedure involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific mutations in the TRMU gene. This genetic insight is crucial for guiding treatment decisions, supporting early intervention efforts, and informing family planning for those with a history of the condition.

The cost of the TRMU Gene Liver Failure Transient Infantile Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides cannot be overstated, as early detection and understanding of the genetic basis of transient infantile liver failure can significantly impact the health outcomes of the affected infants. This test is a key tool in the arsenal against genetic disorders, offering hope and actionable insights for affected families.

Description

TRMU Gene Liver failure transient infantile Genetic Test

Test Name: TRMU Gene Liver failure transient infantile Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Hepatology Nephrology Endocrinology Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for TRMU Gene Liver failure transient infantile NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRMU Gene Liver failure transient infantile NGS Genetic DNA Test gene TRMU

Test Details: TRMU gene is associated with a rare genetic disorder called liver failure transient infantile (LFTI). This disorder is characterized by acute liver failure in infancy, which may be transient or progress to chronic liver disease. It is caused by mutations in the TRMU gene, which is involved in mitochondrial protein synthesis. Next-generation sequencing (NGS) is a genetic testing method that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of LFTI, NGS can be used to identify mutations in the TRMU gene that may be responsible for the disorder. This can help in confirming the diagnosis and providing appropriate genetic counseling to affected families. NGS-based genetic testing involves the sequencing of DNA or RNA samples, followed by bioinformatics analysis to identify any mutations or variants in the TRMU gene. This technology has revolutionized genetic testing, as it allows for a more comprehensive analysis of the genome, enabling the identification of rare and novel genetic variants. In the case of LFTI, NGS genetic testing can aid in the early diagnosis of the disorder, enabling prompt medical intervention and management. It can also help in identifying carriers of the TRMU gene mutation within families, allowing for informed family planning decisions. Overall, NGS genetic testing of the TRMU gene is a valuable tool in the diagnosis and management of liver failure transient infantile, providing crucial information for affected individuals and their families.

Test Name	TRMU Gene Liver failure transient infantile Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hepatology Nephrology Endocrinology Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for TRMU Gene Liver failure transient infantile NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRMU Gene Liver failure transient infantile NGS Genetic DNA Test gene TRMU
Test Details	TRMU gene is associated with a rare genetic disorder called liver failure transient infantile (LFTI). This disorder is characterized by acute liver failure in infancy, which may be transient or progress to chronic liver disease. It is caused by mutations in the TRMU gene, which is involved in mitochondrial protein synthesis. Next-generation sequencing (NGS) is a genetic testing method that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of LFTI, NGS can be used to identify mutations in the TRMU gene that may be responsible for the disorder. This can help in confirming the diagnosis and providing appropriate genetic counseling to affected families. NGS-based genetic testing involves the sequencing of DNA or RNA samples, followed by bioinformatics analysis to identify any mutations or variants in the TRMU gene. This technology has revolutionized genetic testing, as it allows for a more comprehensive analysis of the genome, enabling the identification of rare and novel genetic variants. In the case of LFTI, NGS genetic testing can aid in the early diagnosis of the disorder, enabling prompt medical intervention and management. It can also help in identifying carriers of the TRMU gene mutation within families, allowing for informed family planning decisions. Overall, NGS genetic testing of the TRMU gene is a valuable tool in the diagnosis and management of liver failure transient infantile, providing crucial information for affected individuals and their families.